Osunprotafib is an antitumor agent classified as an immunomodulator, designed to enhance immune responses and increase tumor sensitivity to immune-mediated killing within various cancer therapy applications.… Read more
Osunprotafib is an antitumor agent classified as an immunomodulator, designed to enhance immune responses and increase tumor sensitivity to immune-mediated killing within various cancer therapy applications. As a pharmaceutical-grade compound, it requires rigorous analytical oversight during development and manufacturing. This category provides access to essential analytical tools, including reference standards for the parent active pharmaceutical ingredient, its known impurities, and stable isotope-labelled compounds. Laboratories utilize these high-quality materials for impurity profiling, method validation, and routine quality control procedures to ensure compliance with regulatory standards. By employing stable isotope-labelled internal standards like Osunprotafib-d6, analysts can improve the accuracy of quantification in complex biological matrices, while specific impurity standards allow for the precise identification and monitoring of synthesis byproducts. These reference materials are critical for maintaining the safety and efficacy of the drug substance throughout its lifecycle.